Reduced dietary salt for the prevention of cardiovascular disease

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 9, 2013, Pages

  Adler, Alma J ^a   Taylor, Fiona ^a   Ashton, Kate E ^b   Martin, Nicole ^a   Gottlieb, Sheldon ^c   Ebrahim, Shah ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL; RETRACTED ARTICLE; REVIEW; ADMINISTRATION AND DOSAGE; ADULT; CARDIOVASCULAR DISEASES; HUMAN; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALT INTAKE; SODIUM RESTRICTION; CARDIOVASCULAR DISEASE;

SALT INTAKE;

ADULT; CARDIOVASCULAR DISEASES; DIET, SODIUM-RESTRICTED; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SODIUM CHLORIDE, DIETARY;

EID: 84898759554     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009217.pub2     Document Type: Review

References (66)

1. Chang HY, Hu YW, Yue CS, Wen YW, Yeh WT, Hsu LS, et al.Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition 2006;83:1289-96.
2. The China Salt Substitute Study Collaborative Group. Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. Journal of Hypertension 2007;25:2011-2018.
3. Borhani NO, Tonascia J, Schlundt DG, Prineas RJ, Jefferys JL. Recruitment in the hypertension prevention trial. Controlled Clinical Trials 1989;10(Suppl 3):30-9S.
4. Brown KM, Oberman A, Van Natta ML, Forster JL. Baseline characteristics in the hypertension prevention trial. Controlled Clinical Trials 1989;10(Suppl 3):40-64S.
5. Forster JL, Jeffery RW, VanNatta M, Pirie P. Hypertension prevention trial: do 24-h food records capture usual eating behavior in a dietary study?. American Journal of Clinical Nutrition 1990;51:253-7.
6. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Archives of Internal Medicine 1990;150:153-62.
7. Jeffery RW, French SA, Schmid TL. Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychology 1990;9:315-29.
8. Jeffery RW, Tonascia S, Bjornson BW, Schlundt DG, Sugars C for the Hypertension Prevention Trial Research Group. Treatment in the Hypertension Prevention Trial. Controlled Clinical Trials 1989;10(Suppl 3):65-83S.
9. Meinert CL, Borhani NO, Langford HG. Design, methods, and rationale in the Hypertension Prevention Trial. Controlled Clinical Trials 1989;10(Suppl 3):1-29S.
10. Prudhomme GJ, Canner PL, Cutler JA. Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials 1989;10(Suppl 3):84-94S.
11. Schmid TL, Jeffery RW, Onstad L, Corrigan SA. Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addictive Behaviors 1991;16:151-60.
12. Shah M, Jeffery RW, Laing B, Savre SG, VanNM, Strickland D. Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Journal of the American Dietetic Association 1990;90:69-76.
13. Kwok TCY, Lam LCW, Sea MMM, Goggins W, Woo J. A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition 2012;66:1135-1140.
14. Morgan T, Adam W, Gillies A, Wilson M, Morgan G, Carney S. Hypertension treated by salt restriction. Lancet 1978;1(8058):227-30.
15. Tobari H, Arimoto T, Shimojo N, Yuhara K, Noda H, Yamagishi K, Iso h. Physician-Pharmacist Cooperation Program for Blood Pressure Control in Patients with Hypertension: A Randomized-Controlled Trial. American Journal of Hypertension 2010;23(10):1144-1152.
16. *The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA 1992;267:1213-20.
17. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007;334:885-8.
18. Appel LJ, Hebert PR, Cohen JD, Obarzanek E, Yamamoto M, Buring J, et al.Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology 1995;5:149-55.
19. Hebert PR, Bolt RJ, Borhani NO, Cook NR, Cohen JD, Cutler JA, et al.Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology 1995;5:130-9.
20. Hollis JF, Satterfield S, Smith F, Fouad M, Allender PS, Borhani N, et al.Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology 1995;5:140-8.
21. Hunt SC, Cook NR, Oberman A, Cutler JA, Hennekens CH, Allender PS, et al.Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension 1998;32:393-401.
22. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine 1997;157:657-67.
23. Lasser VI, Raczynski JM, Stevens VJ, Mattfeldt-Beman M, Kumanyika S, Evans M, et al.Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology 1995;5:156-64.
24. Appel LJ, Espeland M, Whelton PK, Dolecek T, Kumanyika S, Applegate WB, et al.Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology 1995;5:119-29.
25. Appel LJ, Espeland MA, Easter L, Wilson AC, Folmar S, Lacy CR. Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine 2001;161:685-93.
26. Bahnson JL, Whelton PK, Appel LJ, Espeland MA, Wofford JL, Rosen R, et al.Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes 1997;1:61-8.
27. Espeland MA, Whelton PK, Kostis JB, Bahnson JL, Ettinger WH, Cutler JA, et al.Predictors and mediators of successful long-term withdrawal from antihypertensive medications. Archives of Family Medicine 1999;8:228-36.
28. Kostis JB, Espeland MA, Appel LJ, Johnson KC, Pierce J, James L. Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology 1998;82:1501-8.
29. Shea MK, Nicklas BJ, Houston DK, Miller ME, Davis CC, Kitzman DW, Espeland MA, Appel LJ, Kritchevsky SB. The effect of intentional weight loss on all-cause mortality in older adults: results of a randomized controlled weight-loss trial. American Journal of Clinical Nutrituion 2011;94:839-846.
30. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, et al.Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 1998;279:839-46.
31. Whelton PK, Bahnson J, Appel LJ, Charleston J, Cosgrove N, Espeland MA, et al.Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society 1997;45:185-93.
32. Bentley BB. Dietary sodium in heart failure. USA: University of Kentucky, 2006.
33. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Low sodium diet and pregnancy-induced hypertension: a multi-centre randomised controlled trial. British Journal of Obstetrics and Gynaecology 1998;105:430-4.
34. Koopman H, Deville W, van Eijk J, Donker AJM, Spreeuwenberg C. Diet or diuretic? Treatment of newly diagnosed mild to moderate hypertension in the elderly. Journal of Human Hypertension 1997;11:807-12.
35. Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, et al.Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: Long-term effects. American Heart Journal 2003;145:459-66.
36. van der Post JA, van Buul BJ, Hart AA, van Heerikhuize JJ, Pesman G, Legros JJ, et al.Vasopressin and oxytocin levels during normal pregnancy: effects of chronic dietary sodium restriction. Journal of Endocrinology 1997;152:345-54.
37. Velloso LG, Alonso RR, Ciscato CM, Barretto AC, Bellotti G, Pileggi F. Diet with usual quantity of salt in hospital treatment of congestive heart insufficiency. Arquivos Brasileiros de Cardiologia 1991;57:465-8.
38. Aung MY, Yuasa M, Moolphate S, Nedsuwan S, Yokokawa H, Kitajima T, Minematus K, Tanimura S, Fukuda H, Hiratsuka Y, Ono K, Kawai S, Marui E. Reducing salt intake for prevention of cardiovascular disease in high-risk patients by advanced health education intervention (RESIP-CVD study), Northern Thailand: study protocol for a cluster randomised trial. Trials 2012;13:158.
39. Alderman MH. Reducing dietary sodium. The case for caution. JAMA 2010;303:448-9.
40. Allender S, Scarborough P, Peto V, Rayner M, Leal J, Luengo-Fernandez R, et al.European Cardiovascular Disease Statistics 2008. III Edition. European Heart Network, 2008.
41. Alli C, Avanzini F, Bettelli G, Bonati M, Colombo F, Corso R, et al.Feasibility of a long-term low-sodium diet in mild hypertension. Journal of Human Hypertension 1992;6:281-6.
42. Arroll B, Beaglehole R. Salt restriction and physical activity in treated hypertensives. New Zealand Medical Journal 1995;108:266-8.
43. Cappuccio FP. Sodium, potassium, calcium and magnesium and cardiovascular risk. J Cardiovasc Risk 2000;7:1-3.
44. Costa FV, Ambrosioni E, Montebugnoli L, Paccaloni L, Vasconi L, Magnani B. Effects of low-salt diet and of acute salt loading on blood pressure and intralymphatic sodium concentration in young subjects with borderline hypertension. Clinical Science 1981;61(Suppl 7):21-3S.
45. DiNicolantonio J, Di Pasquale P, Taylor RS, Hackam DG. Retraction notice: Low sodium versus normal sodium diets in systolic heart failure: systematic review and meta-analysis. Heart Online First 12.March 2013; Vol. 10.1136/heartjnl-2012-302337.
46. Editor's Note. http://heart.bmj.com/content/suppl/2012/08/21/heartjnl-2012-302337.DC2/heartjnl-2012-302337supp.pdf.
47. Elliot P. Sodium and blood pressure: a review of the evidence from controlled trials of sodium reduction and epidemiological studies. Klinische Wochenschrift 1991;69(Suppl 25):3-10.
48. Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ 1996;312(7041):1249-53.
49. He J, Whelton PK. Commentary: Salt intake, hypertension and risk of cardiovascular disease: an important public health challenge. International Journal of Epidemiology 2002;31:327-31.
50. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD004937]
51. He FJ, MacGregor GA. Reducing population salt intake worldwide: from evidence to implementation. Progress in Cardiovascular Diseases 2010;52(5):363-82.
52. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011.
53. Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003656.pub2]
54. Jürgens G, Graudal NA. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD004022.pub2]
55. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
56. Mackay J, Mensah G editors. Atlas of Heart Disease and Stroke. World Health Organization, 2004.
57. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al.Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
58. McHorney CA, Ware Jr. JE, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care 1993;31:247-63.
59. Morgan T, Anderson A. Sodium restriction can delay the return of hypertension in patients previously well-controlled on drug therapy. Canadian Journal of Physiology and Pharmacology 1987;65:1720-5.
60. National Institute for Health & Clinical Excellence (NICE). Prevention of cardiovascular disease at population level. Public health guidance 25. www.nice.org.uk/guidance/PH25 (accessed 31st May 2011).
61. Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal-sodium diet compared with low-sodium diet in compensated conestive heart failure: is sodium an old enemy or a new friend?. Clin Scie 2008;114:221-230.
62. Scientific Advisory Committee on Nutrition (SACN). Salt and health. http://www.sacn.gov.uk/pdf/salt-final.pdf (assessed 31st May 2011).
63. Silman AJ, Locke C, Mitchell P, Humpherson P. Evaluation of the effectiveness of a low sodium diet in the treatment of mild to moderate hypertension. Lancet 1983;1(8335):1179-82.
64. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009;339:b4567.
65. Thaler BI, Paulin JM, Phelan EL, Simpson FO. A pilot study to test the feasibility of salt restriction in a community. New Zealand Medical Journal 1982;95:839-42.
66. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al.Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002;288:1882-8.